Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
Abstract
Non-ischemic dilated cardiomyopathy (DCM) patients on medical therapy have a high morbidity and mortality. The use of stem cell therapy in this patient subset has not been previously reported. Cardiac magnetic resonance (CMR) is the gold standard modality for quantifying ventricular function. We sought to evaluate the utility of CMR in assessing outcomes of stem cell therapy in DCM.
Document Preview